Related Experiment Videos
Effect of cyclophosphamide on the growth of Rickettsia sennetsu in experimentally infected mice
Abstract:
The growth rate of Rickettsia sennetsu, the etiological agent of sennetsu rickettsiosis, a special type of infectious mononucleosis found in western Japan, is very low when the ordinary experimental methods used for other members of the rickettsiae are employed. Attempts have been made to increase its growth the rickettsiae are employed. Attempts have been made to increase its growth rate in cells and animals. By treating mice with cyclophosphamide, considerable enhancement of growth of the rickettsia was observed. In the drug-treated mice, infective titers expressed as mean lethal dose in the spleens reached 10(8,5) in animals treated by the intraperitoneal route three times at 5-day intervals with 0.33 mg/g (body weight). Infective titers in drug-treated mice were more than 100-fold above those of the infected non-drug-treated mice. In peritoneal cells of drug-treated mice rickettsial particles were observed in great abundance. The numbers of cells containing rickettsiae almost paralleled the infective titers of the spleens in each group in mice. Lymph nodes and spleens of the drug-treated mice diminished in size during infection.
Insights
Cyclophosphamide treatment significantly enhances the growth of Rickettsia sennetsu, the cause of sennetsu rickettsiosis. This breakthrough improves understanding of Rickettsia growth and infectious disease progression.
Area of Science:
- Microbiology
- Infectious Diseases
- Immunology
Background:
- Rickettsia sennetsu causes sennetsu rickettsiosis, a form of infectious mononucleosis endemic to western Japan.
- The growth rate of Rickettsia sennetsu is typically very low using standard experimental methods.
- Enhancing Rickettsia sennetsu growth is crucial for studying its pathogenesis and developing treatments.
Purpose of the Study:
- To investigate methods for increasing the growth rate of Rickettsia sennetsu in vivo.
- To evaluate the efficacy of cyclophosphamide in enhancing Rickettsia sennetsu replication.
- To quantify the impact of cyclophosphamide on Rickettsia sennetsu infectivity.
Main Methods:
- Mice were treated with cyclophosphamide via intraperitoneal injection at specific intervals and dosages.
- Infective titers (mean lethal dose) in the spleens of treated and untreated mice were determined.
- Rickettsial particle abundance was assessed in peritoneal cells using microscopy.
- Lymph node and spleen sizes were measured in infected mice.
Main Results:
- Cyclophosphamide treatment led to a significant enhancement of Rickettsia sennetsu growth.
- Infective titers in the spleens of treated mice reached 10(8.5), over 100-fold higher than in untreated mice.
- Abundant rickettsial particles were observed in peritoneal cells of cyclophosphamide-treated mice.
- Lymph nodes and spleens showed diminished size in drug-treated infected mice.
Conclusions:
- Cyclophosphamide administration effectively promotes Rickettsia sennetsu growth in mice.
- This immunosuppressive strategy allows for higher Rickettsia sennetsu loads, facilitating further research.
- The findings provide a valuable model for studying Rickettsia sennetsu infection dynamics.